Aims Metformin use has been associated with a decreased risk of some cancers, although
data on head and neck cancer (HNC) are scarce. We explored the relation between the use …

Diabetes mellitus type II (DM) and immune cell infiltration determine patient outcome in
many tumor entities. Here we studied a possible link between the metabolic and immune …

Head and neck squamous cell carcinoma (HNSCC) is significantly underrepresented in
worldwide cancer research, yet survival rates for the disease have remained static for over …

Objective: Metformin is an oral anti-hyperglycemic agent used to treat type 2 diabetes
mellitus (DM). In vitro and animal models have shown that metformin can prevent the …

Aims The association between type 2 diabetes mellitus (T2DM) and risk of head and neck
cancer (HNC) remains unclear. This study aims to perform a system review and meta …

Background Metabolic syndrome (MetS) and its components are associated with increased
risks of several cancers. However, the relationship between MetS and upper tract urothelial …

Simple Summary The incidence of hypopharyngeal cancer has been rapidly increasing, but
hypopharyngeal cancer has a poorer prognosis compared to other head and neck cancers …

This study aimed to clarify the risk factors of head and neck cancer (HNC) mortality, relative
to those of all-cause and all-cancer mortalities, using the Korean National Health Insurance …

The aim of this study is to evaluate the association between metabolic disorders and the risk
of nasopharyngeal carcinoma, considering different histological subtypes. Between 1992 …

Introduction Head and neck cancer squamous cell carcinoma (HNSCC) is the sixth most
common cancer internationally. Established risk factors include smoking, alcohol and …